EcoDrugPlus

Ensembl ID : ENSOTSG00005043324
Gene Symbol: PSMD11B
1 Cross references
214 Possible Orthologues:

Ensembl ID : ENSOTSG00005003425
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSOTSG00005044328
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOTSG00005003384
Gene Symbol: -
Cross references: -
85 Possible Orthologues:

Ensembl ID : ENSOTSG00005004357
Gene Symbol: -
Cross references: -
24 Possible Orthologues:

Ensembl ID : ENSOTSG00005043980
Gene Symbol: -
Cross references: -
350 Possible Orthologues:

Ensembl ID : ENSOTSG00005032233
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSOTSG00005004589
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOTSG00005007889
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSOTSG00005031836
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSOTSG00005031660
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSOTSG00005031656
Gene Symbol: PLK4
1 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).